Search 

Founded in 2000, Nexstim is a medical device company developing non-invasive, image-guided transcranial magnetic stimulation (TMS) for brain diagnostics and therapy. Diagnostic applications have been designed for perioperative procedures of tumor and epilepsy surgery as well as stroke rehabilitation screening. Therapeutic applications include but are not limited to stroke rehabilitation and drug resistive depression treatment.

Nexstim Oy headquarters and international operations are located in Helsinki, Finland. Nexstim Inc., United States headquarters is based out of Alpharetta, GA and provides sales, service, support, and marketing for North America.

Ocuspecto develops an automatic visual system measuring device which will revolutionize current screening practices. The invention is based on long term research work done by ophthalmologist and Ocuspecto founder Markku Leinonen who needed a method to study visual fields of small children.

The product Ocusweep is based on innovative, patented technology, which accurately measures eye movements without expensive eye-tracker. Ocusweep is patient-friendly, easy-to-use and affordable system, while making testing error-proof. Nursing staff or opticians are able to execute the tests on behalf of physicians, optometrists or ophthalmologists, saving costs and time to results. Ocusweep is light-weight (5kg) and mobile class I medical device which combines several existing devices into one.